πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12213990

A3 adenosine receptor ligand for use for achieving a fat loss effect

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11291681

Method for treating fibrotic liver tissue using Cl-IB-MECA

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10780106

Method for treating NASH accompanied by fibrosis using Cl-IB-MECA

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265337

Use of A3 adenosine receptor agonist in osteoarthritis treatment

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9549943

A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387220

Method for inducing hepatocyte proliferation and uses thereof

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9102698

Process for the synthesis of IB-MECA

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987228

Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-id

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846635

Method for inducing hepatocyte proliferation and uses thereof

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557790

A3 adenoside receptor agonists for the reduction of intraocular pressure

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541182

Biological marker for inflammation

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825102

Treatment of dry eye conditions

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589075

Use of an adenosine A3 receptor agonist for inhibition of viral replication

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465715

Method for treatment of multiple sclerosis

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189706

C2,5β€²-disubstituted and N6,C2,5β€²-trisubstituted adenosine derivatives and pharmaceutical c

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141553

A3AR agonists for the treatment of inflammatory arthritis

Can-Fite Biopharma Ltd. Israel Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112574

C2,8-disubstituted adenosine derivatives and their different uses

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7084127

C2,5β€²-disubstituted and N6, C2,5β€²-trisubstituted adenosine derivatives and their different

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7064112

Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6911435

Method of treating leukopenia with adenosine

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6790839

Pharmaceutical administration of adenosine agonists

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6638914

Pharmaceutical administration of adenosine agonists

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6537587

Compositions containing muscle-derived active agents

CAN-FITE BIOPHARMA LTD. Β· Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired